Market Cap | ₹8.24Cr |
ROE | -17.01% |
P/E Ratio(TTM) | -9.81 |
EPS(TTM) | -0.21 |
P/B Ratio | 2.08 |
Dividend Yield | 0.00% |
Industry P/E | 34.56 |
Book Value | 0.99 |
Debt to Equity | 2.18 |
Face Value | 1 |
Parent Organisation | Vivanza Biosciences Limited |
Managing Director | Mr. Jayendra Mehta |
BSE Symbol | 530057 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.11 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.32 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.07 | ||
Wockhardt | NA (0.00%) | -152.04 |